What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

Proton therapy is an advanced radiation treatment that precisely targets tumors with a goal of limiting harm to healthy tissue. It may help reduce short- and long-term side effects, lower the risk of ...

There's a growing interest in the use of bone-modifying agents, or BMAs, known as bisphosphonates in the cancer patient population. But these agents can cause short- and long-term side effects. What’s ...

After being diagnosed and treated for breast cancer three separate times, Liza Bernstein, 51, of Los Angeles has her life, her family and friends, her hopes and dreams, her art, and a renewed sense of ...

Many cancer patients try to quit smoking after diagnosis but can’t because of nicotine’s stronghold on their bodies. Others are so stressed they continue to use cigarettes as a crutch. Researchers at ...

Worried about health effects from the U.S.’s increasingly smoky summers? One day, not far in the future, you may be able to pop a few pills that will help your cells pinpoint and extract the worst of ...

The CSRN is a multi-center effort, funded by the National Cancer Institute, and is the first large-scale network to focus on cancer screening. Fred Hutch Cancer Center serves as the coordinating and ...

Endometriosis, a painful condition that affects one in 10 reproductive-age women in the U.S., has been linked to childhood physical and sexual abuse, according to findings published today in the ...

Fred Hutch researcher Dr. Andrew McGuire and his team report encouraging results in early laboratory test of a new concept in vaccines for Epstein-Barr virus, the bug that not only causes ...